Trinity Biotech
NasdaqGS:TRIB
$ 0,71
+ $0,01 (1,43%)
0,71 $
+$0,01 (1,43%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-1,32
Earnings Per Share
$3,30
Revenue Per Share
34,83%
Gross Margin %
$0,01 B
Market Cap
$0,09 B
Long-Term Debt
Earnings Per Share
$-1,32
Revenue Per Share
$3,30
Gross Margin %
34,83%
Market Cap
$0,01 B
Long-Term Debt
$0,09 B

Financials

Year Year 2024 2023
EPS Earnings Per Share $-1,32 $-4,52
Earnings Earnings $-24,59M $-42,80M
RPS Revenue Per Share $3,30 $6,00
Revenue Revenue $61,56M $56,83M
OCF Operating Cash Flow $-4,19M $-1,01M
FCF Free Cash Flow $-5,61M $0,00M
OM Operating Margin -22,26% -28,29%
GM % Gross Margin % 34,83% 34,22%
FCFS Free Cash Flow Per Share $-0,79 $-1,86
LT Debt Long-Term Debt $87,79M $54,65M
Sha. Stocks 18,63M 9,47M
×